Scopolamine Market
Scopolamine is an alkaloid drug extracted from a plant called henbane to treat nausea and motion sickness and further to dilate the pupil in ophthalmic procedures. Scopolamine belongs to a class of drugs called anticholinergic. Scopolamine is a tropane alkaloid isolated from members of the Solanaceae family of plants, similar to atropine and hyoscyamine, all of which structurally mimic the natural neurotransmitter acetylcholine. It works by blocking the activity of the neurotransmitter acetylcholine, which stimulates the part of the brain that triggers nausea and vomiting, involuntary muscle movement in the lungs, and the gastrointestinal and urinary tracts. Scopolamine is also used in medicine as a sedative or hypnotic and sometimes with morphine to relieve pain. Scopolamine has also been prescribed ‘off label’ for depression, asthma, as a smoking-cessation remedy, and to relieve the nausea that accompanies chemotherapy. According to data published by National Center for Biotechnology Information, in July 2019, Scopolamine is an anticholinergic belladonna alkaloid that, through competitive inhibition of muscarinic receptors, affects parasympathetic nervous system function and acts on smooth muscles that respond to acetylcholine but lack cholinergic innervation. Formulated as a patch, scopolamine is released continuously over three days and remains detectable in urine over a period of 108 hours. Scopolamine is contraindicated in angle-closure glaucoma and should be used with caution in patients with open-angle glaucoma due to scopolamine's ability to increase intraocular pressure.
Market Dynamics
Increasing global population suffering from stress and anxiety disorders is expected to fuel growth of the global scopolamine market. For instance, in March 2022, according to data published by the GOQii survey on the stress and mental health status of Indians, the GOQii Survey indicates that 29.31% of Indians were suffering from depression in 2021. Stress was the cause for seven out of ten patients suffering from gastrointestinal pain. According to the National Center for the Biotechnology Information around 12 percent Trusted Source of adults in the United States have Irritable bowel syndrome due to increasing stress after economic loss in covid-19 pandemic. Women are twice as likely to have Irritable bowel syndrome as men. As many as three-quarters Trusted Source of people with Irritable bowel syndrome report stress. The nervous system controls the gut and also responds to psychological stress.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 19 market data tables and 23 figures on "Global Scopolamine Market” - forecast to 2030
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWe help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients